Operation New Drugs: China Extends Fast Track System Beyond Cancer

 
• By Brian Yang

Innovative new drugs in five categories are now eligible for fast track approvals in China, with the timescale shortened from 18 months normally to six months under the expanded system.

Priority Review Voucher
China offers fast-track reviews to conditions other than cancer

More from China

More from Asia